FIELD: medicine, veterinary science.
SUBSTANCE: the present innovation deals with applying medicinal preparations based upon potassium alums externally. Natural potassium alums should be applied either externally as 0.5-2%-solution in combination with inner intake due to bottle-feeding or being the constituent of an ointment that contains 25% potassium alums, not more.
EFFECT: higher efficiency of therapy.
2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| WOUND-HEALING AGENT | 1986 |
|
RU2063237C1 |
| OINTMENT FOR THE TREATMENT OF BURNS AND INFECTED WOUNDS AND A METHOD FOR TREATMENT WITH ITS USE | 2021 |
|
RU2778778C1 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| AGENT FOR TREATMENT OF UNHEALING INFECTED ULCERS AND WOUNDS | 1998 |
|
RU2147240C1 |
| AGENT OF PEPTIDE STRUCTURE POSSESSING ANTI-INFLAMMATORY, ANTIBACTERIAL, WOUND-HEALING, REGENERATIVE, ANALGESIC, BURNTREATING ACTION AND BASED DOSAGE FORMS | 2012 |
|
RU2517213C2 |
| ANTI-INFLAMMATORY OINTMENT | 2004 |
|
RU2280458C1 |
| TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
| WOUND-HEALING, ANTI-INFLAMMATORY AND ANTI-INFECTIOUS MEDICINAL PREPARATION | 2000 |
|
RU2173155C1 |
| CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
| METHOD OF PRODUCING AND USING SOLUTION AND LINIMENT OF FURAZOLIDONE | 2018 |
|
RU2690493C1 |
